U.S. patent application number 13/658384 was filed with the patent office on 2013-02-21 for device and method for treatment of gastroesophageal reflux disease.
This patent application is currently assigned to BOSTON SCIENTIFIC SCIMED, INC.. The applicant listed for this patent is BOSTON SCIENTIFIC SCIMED, INC.. Invention is credited to Robert A. Ganz, Brian D. ZELICKSON.
Application Number | 20130046146 13/658384 |
Document ID | / |
Family ID | 25014902 |
Filed Date | 2013-02-21 |
United States Patent
Application |
20130046146 |
Kind Code |
A1 |
ZELICKSON; Brian D. ; et
al. |
February 21, 2013 |
Device and Method for Treatment of Gastroesophageal Reflux
Disease
Abstract
A lower esophageal sphincter tightening device for treating
gastroesophageal reflux disease which includes an insertion device,
an energy source, and an energy transmitting device. The insertion
device, by insertion through a body opening, positions the energy
transmitting device in the proximity of the lower esophageal
sphincter. The energy source generates and transmits energy via the
insertion device to the energy transmitting device which directs
the transmitted energy onto the lower esophageal sphincter which is
comprised largely of collagen. The energy source transmits energy
at a level sufficient to cause heating of the sphincter's collagen
resulting in a shrinkage of the collagen and a tightening of the
sphincter.
Inventors: |
ZELICKSON; Brian D.;
(Minneapolis, MN) ; Ganz; Robert A.; (Minneapolis,
MN) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
BOSTON SCIENTIFIC SCIMED, INC.; |
Maple Grove |
MN |
US |
|
|
Assignee: |
BOSTON SCIENTIFIC SCIMED,
INC.
Maple Grove
MN
|
Family ID: |
25014902 |
Appl. No.: |
13/658384 |
Filed: |
October 23, 2012 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
13071192 |
Mar 24, 2011 |
|
|
|
13658384 |
|
|
|
|
12839112 |
Jul 19, 2010 |
7933659 |
|
|
13071192 |
|
|
|
|
12136730 |
Jun 10, 2008 |
7761169 |
|
|
12839112 |
|
|
|
|
11279025 |
Apr 7, 2006 |
7400929 |
|
|
12136730 |
|
|
|
|
10633820 |
Aug 4, 2003 |
7043307 |
|
|
11279025 |
|
|
|
|
09971315 |
Oct 4, 2001 |
6604004 |
|
|
10633820 |
|
|
|
|
09475580 |
Dec 30, 1999 |
6321121 |
|
|
09971315 |
|
|
|
|
08749723 |
Nov 15, 1996 |
6073052 |
|
|
09475580 |
|
|
|
|
Current U.S.
Class: |
600/162 ;
600/249; 607/101 |
Current CPC
Class: |
A61B 18/1492 20130101;
A61B 18/20 20130101; A61B 18/08 20130101; A61B 2018/00214 20130101;
A61B 2018/00553 20130101; A61B 18/1815 20130101; A61B 2018/00011
20130101; A61B 1/00082 20130101; A61B 1/018 20130101 |
Class at
Publication: |
600/162 ;
607/101; 600/249 |
International
Class: |
A61N 5/02 20060101
A61N005/02; A61B 1/00 20060101 A61B001/00; A61B 1/06 20060101
A61B001/06 |
Claims
1.-74. (canceled)
75. A medical treatment system, comprising: an elongate insertion
device configured for insertion into an opening of a body; an
energy source disposed outside the body; an energy transmitting
device located at a distal end of the insertion device, the energy
transmitting device comprising an expandable portion which extends
radially from the insertion device, and an antenna located in an
exterior surface of the expandable portion, the antenna configured
to transmit energy generated by the energy source to a target
tissue area in the body; and a manifold through which a
transmission line of the energy source passes, the transmission
line coupled to the energy transmitting device, wherein the distal
end of the insertion device is controllable to position the energy
transmitting device in relation to the target tissue area.
76. The system of claim 75, wherein the expandable portion
comprises a balloon.
77. The system of claim 76, further comprising an inflation device
one of inflating and deflating the balloon, the inflation device
including a conduit passing through the manifold and forming at
least part of the catheter, the catheter coupling to the
balloon.
78. The system of claim 76, wherein the inflation device inflates
the balloon using one of air, fluid and gel.
79. The system of claim 76, further comprising a source of a
coolant fluid which cools the balloon and target tissue in contact
therewith.
80. The system of claim 77, wherein the energy transmitting device
includes a plurality of strips of energy transmitting material
distributed over a first portion of the exterior surface of the
balloon which, when inflated in the deployed position, contacts the
target tissue.
81. The system of claim 80, wherein the energy transmitting
material is spaced circumferentially about the exterior surface of
the balloon.
82. The system of claim 77, wherein the first portion of the
balloon is positioned and shaped so that, when the balloon is
inflated at a desired position a gastrointestinal tract of the
body, the energy transmitting material contacts a target region of
tissue adjacent a gastroesophageal junction.
83. The system of claim 82, wherein the inflatable balloon is
configured and dimensioned so that, when inflated in a desired
position within the gastrointestinal tract, a second portion
thereof extends distally beyond the first portion thereof into a
proximal portion of the stomach.
84. The system of claim 75, further comprising a vision system
permitting a user to view the energy transmitting device when the
expandable portion is in a deployed position.
85. The system of claim 75, a portion of the transmission line
within the manifold forming a part of a catheter which, in an
operative configuration, passes through the elongate insertion
device.
86. A medical treatment system, comprising: an elongate insertion
device configured for insertion into an opening of a body; an
energy source including a transmission line received in the
elongate insertion device; an energy transmitting device located at
a distal end of the insertion device, the energy transmitting
device comprising an expandable portion which extends radially from
the insertion device, and an antenna located in an exterior surface
of the expandable portion, the antenna configured to transmit
energy generated by the energy source to a target tissue area in
the body; and wherein the distal end of the insertion device is
controllable to position the energy transmitting device in relation
to the target tissue area.
87. The system of claim 86, further comprising a manifold through
which the transmission line passes a portion of the transmission
line within the manifold forming at least part of a catheter, the
catheter passing through the elongate insertion device through the
one of the ports and coupling to the energy transmitting
device.
88. The system of claim 87, further comprising an inflation device
one of inflating and deflating the expandable portion, the
inflation device including a conduit passing through the manifold
and forming at least part of the catheter, the catheter coupling to
the expandable portion.
89. The system of claim 86, further comprising a light source
illuminating an area surround the distal end by light transmitted
through an optical cable which passes through one of the ports.
90. The system of claim 88, wherein the expandable portion
comprises a balloon.
91. The system of claim 90, wherein the inflation device inflates
the balloon using one of air, fluid and gel.
92. The system of claim 86, further comprising a vision system
permitting a user to view the energy transmitting device when the
expandable portion is in a deployed position.
93. The system of claim 92, wherein the vision system includes an
eye piece disposed at the proximal end of the elongate insertion
device.
94. The system of claim 86, further comprising a control mechanism
at a proximal portion of the elongate insertion device controlling
movement of the energy transmitting device.
95. The system of claim 86, wherein the antenna comprises a
plurality of electrically conductive elements spaced
circumferentially about the exterior surface of the expandable
portion.
96. The system of claim 86, wherein the elongate insertion device
includes a plurality of ports at a proximal end thereof, the
transmission line being received in the elongate insertion device
via a first one of the ports.
97. A medical treatment system, comprising: an elongate insertion
device configured for insertion into an opening of a body; an
energy source disposed outside the body; an energy transmitting
device at a distal end of the insertion device, the energy
transmitting device comprising a balloon which extends radially
from the insertion device, and an antenna located in an exterior
surface of the balloon, the antenna configured to transmit energy
generated by the energy source to a target tissue area in the body;
and a manifold through which a transmission line of the energy
source passes, the transmission line coupled to the energy
transmitting device, wherein the distal end of the insertion device
is controllable to position the energy transmitting device in
relation to the target tissue area.
98. The system of claim 97, a portion of the transmission line
within the manifold forming a part of a catheter which, in an
operative configuration, passes through the elongate insertion
device.
Description
BACKGROUND OF THE INVENTION
[0001] The invention pertains to the treatment of gastroesophageal
reflux disease (GERD).
[0002] GERD is a major health problem in the United States and
worldwide. It affects tens of millions of people and costs billions
of dollars to treat. GERD is the reflux of gastric contents from a
stomach into a lower area of an esophagus. The gastric contents
include acid secreted by the stomach which causes discomfort and
eventual damage to an inner lining of the esophagus if left
untreated.
[0003] The gastric contents are normally prevented from entering
the esophagus by a lower esophageal sphincter (LES) mechanism. The
LES is a physiologic, non-anatomic area involving the lower 3
centimeters of the esophagus and like other smooth muscle
sphincters in the body, anal or urinary, it is tonically contracted
to prevent reflux. A healthy LES opens for a brief period of
several seconds in response to swallowing to allow the passage of
food. It then quickly regains its tone when the food has
passed.
[0004] GERD occurs when the sphincter mechanism of the LES fails to
work properly. Generally, GERD takes one of three forms: (i)
complete weakness of the sphincter musculature in response to a
hiatal hernia or an intrinsic weakness that occurs commonly
resulting in free reflux, which is poorly understood; (ii) partial
weakness of the sphincter that allows reflux when stressed such as
a Valsalva maneuver; or (iii) transient or sudden inappropriate
relaxation of an otherwise normally toned sphincter.
[0005] Treatment of a weakened or inappropriately relaxing
sphincter can be either medical or surgical. Known medical
treatments include measures or medications that attempt to decrease
acid secretion, increase gastric emptying or strengthen the LES.
However, the medications are expensive and the measures typically
have to be continued on a life long basis.
[0006] A more permanent treatment method for GERD can be performed
surgically. Surgical methods attempt to strengthen the LES by
incising the stomach and wrapping a portion of the stomach around
the lower section of the esophagus. This technique is known as a
fundoplication. However, surgical treatment requires longer post
treatment care, increased pain and recovery time, as well as the
associated risks with any surgical procedure.
[0007] The latest developments for treating GERD have attempted to
provide a minimally invasive procedure to strengthen the lower
esophageal area. One such treatment is disclosed by C. P. Swain et
al., Knot Tying At Flexible Endoscopy, Gastrointestinal Endoscopy,
1994; 40:722-29, that calls for endoscopic sewing in the lower
esophageal area. However the sewn portion of the esophagus in the
Swain technique may relax again requiring further or alternate
forms of treatment. Another technique disclosed by Donahue injects
noxious, scarring substances into the lower esophageal area to
create a fibrous reaction. P. E. Donahue; et. al., Endoscopic
Ultrasonography Verifies Effect On Endoscopic Treatment Of Reflux
In Dogs And Man, Surgical Endoscopy, 1993; 7:524-28. However, the
Donahue technique may require numerous and repeated injections.
[0008] The esophagus and LES are composed of three tissue layers; a
mucosa or inner layer, a submucosa or middle layer, and a muscle or
an outer layer. The submucosa layer is largely composed of
collagen. It is well-known that heating of collagen tissue within
an appropriate temperature range results in a tightening or
shrinkage of the collagen tissue. However, there exists no known
device or technique for strengthening the LES by shrinkage of
collagen tissue as a means to treat GERD.
SUMMARY OF THE INVENTION
[0009] The invention discloses a device and method to prevent
gastroesophageal reflux or GERD. The device comprises an insertion
device, an energy source, and an energy transmitting device. The
insertion device has a proximal end connected to the energy source
and a distal end connected to the energy transmitting device. The
energy source generates and transmits energy to the energy
transmitting device through the insertion device. The energy
transmitting device then radiates and directs the transmitted
energy onto a target area. The insertion device positions the
energy transmitting device in the proximity of a lower esophageal
sphincter, such that the sphincter tissue becomes the target area,
of the energy transmitting device.
[0010] The energy source then generates and transmits energy to the
energy transmitting device which radiates the energy onto the
sphincter tissue. The sphincter tissue absorbs the radiated energy
which generates heat within the sphincter tissue. The sphincter
tissue is largely comprised of collagen which exhibits shrinkage
when heated.
[0011] The energy source generates and transmits energy at a level
sufficient to cause heating of the sphincter tissue to a
temperature of between 50.degree. C. and 70.degree. C. (preferably
between 63.degree. C. and 65.degree. C.) within a time period of
between about 1 microsecond and 1 minute. Heating the sphincter
tissue within the appropriate range achieves sufficient collagen
shrinkage to tighten the lower esophageal sphincter and prevent
reflux.
BRIEF DESCRIPTION OF THE DRAWINGS
[0012] FIG. 1 is a perspective view of a lower esophageal sphincter
tightening device of the present invention.
[0013] FIG. 2 is a cutaway diagram of an esophagus.
[0014] FIG. 3 is a perspective view of a second embodiment of the
lower esophageal sphincter tightening device of the present
invention.
[0015] FIG. 4 is a perspective view of a third embodiment of the
lower esophageal sphincter tightening device of the present
invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0016] In FIG. 1, a preferred embodiment of a lower esophageal
sphincter (LES) tightening device 10 is shown in use. The LES
tightening device 10 comprises an insertion device 12, an energy
source 14 and an energy transmitting device 16. As shown in FIG. 1,
the LES tightening device 10 could also include an inflation device
18 and a balloon 20.
[0017] In a preferred embodiment, the insertion device 12 is an
endoscope as shown in FIGS. 1, 3 and 4. However, workers skilled in
the art will recognize that a catheter or other similar device
could also be used. As shown in FIG. 1, the insertion device 12 has
a proximal end 22 and a distal end 24. Additionally, the insertion
device 12 could include an eye piece 26, a light source 28 and a
control means 30. A series of ports 32 provide access from the
proximal end 22 to the distal end 24 through lumens located within
the interior of the insertion device 12 along its longitudinal
access.
[0018] The energy source 14 is located at the proximal end 22 of
the insertion device 12. The energy source 14 generates and
transmits energy to the energy transmitting device 16 located at
the distal end 24 of the insertion device 12. The energy source 14
is connected to the energy transmitting device 16 by a transmission
line 34 which passes through a manifold 36. Within the manifold 36,
the transmission line 34 becomes part of a catheter 38 that is fed
through one of the ports 32 at the proximal end 22. The catheter 38
then passes down one of the interior lumens of the insertion device
12 and is connected to the energy transmitting device 16 at the
distal end 24.
[0019] In a preferred embodiment, the insertion device 12 enters a
body opening 40 and passes down an esophagus 42 until the distal
end 24 is in the proximity of a lower esophageal sphincter 44. The
control means 30 aid in positioning the distal end 24 of the
insertion device 12. Observation through eye piece 26 insures
proper placement of the distal end 24. Observation is enabled by
the light source 28 which illuminates the area surrounding the
distal end 24 by light transmitted through an optical cable 45
which passes through one of the ports 32 and down another interior
lumen. The optical cable 45 is preferably a fiber optic bundle.
[0020] The energy transmitting device 16 radiates and directs
energy received through the catheter 38 from the energy source 14
onto a target area. The distal end 24 of the insertion device 12 is
therefore located such that the target area of the energy
transmitting device 16 is directed at tissue comprising the lower
esophageal sphincter 44. Once the energy transmitting device 16 is
properly positioned, the energy source 14 can transmit energy it
has generated to the energy transmitting device 16 through the
catheter 38.
[0021] The transmitted energy is then radiated and directed by the
energy transmitting device 16 onto the lower esophageal sphincter
44 tissue. The lower esophageal sphincter 44 tissue absorbs the
energy resulting in the generation of heat within the tissue due to
thermal conduction. The lower esophageal sphincter 44 tissue is
comprised largely of collagen which will exhibit shrinkage
characteristics over an appropriate time temperature relationship
prior to being damaged or destroyed.
[0022] The appropriate time period to satisfy the time temperature
relationship is dependent upon the temperature of the treated
tissue, which in turn is dependent upon the level of energy
generated in the energy source 14 and radiated by the energy
transmitting device 16, The desired tissue temperature in the
target area is between 50.degree. C. and 70.degree. C., with a
preferred level between 63.degree. C. and 65.degree. C. This
temperature increase can be achieved within a period of time
between one microsecond and one minute dependent upon the amount
and type of energy generated within the energy source 14. In a
preferred embodiment, the energy source 14 generates radiant energy
(e.g. RF or microwave electromagnetic energy) which is transmitted
by a transmission line 34 (such as a coaxial cable) that is then
contained within the catheter 38 and connects to the energy
transmitting device 16. The energy transmitting device 16 is
preferably an antenna or a directional antenna.
[0023] The LES tightening device 10 can additionally include the
inflation device 18 and the balloon 20. Once the energy
transmitting device 16 is properly positioned, the balloon 20 is
located at the distal end 24 of the insertion device 12 and
encapsulates the energy transmitting device 16 as shown in FIG. 1.
The inflation device 18, located at the proximal end 22, inflates
or deflates the balloon 20 via a conduit 48. The conduit 48
connects the inflation device 18 to the balloon 20 by passing
through the manifold 36, wherein the conduit 48 becomes part of the
catheter 38. Air, fluid or gel could be used by the inflation
device 18 to inflate the balloon 20. The size of the balloon 20 can
be adjusted to maintain proper placement of the energy transmitting
device 16 in relation to the lower esophageal sphincter 44 tissue
and/or control the amount of collagen shrinkage and therefore
control the amount of sphincter tightening.
[0024] In a preferred embodiment, the balloon 20 can be either a
noncompliant balloon or a compliant balloon. The size of a
compliant balloon can be controlled by observation through the eye
piece 26, injection of a radiopaque fluid such as fluorochrome into
the balloon 20 and viewing on a fluoroscope, or monitoring the
pressure of the balloon 20.
[0025] FIG. 2 is a cutaway schematic view (not to scale) of the
tissue comprising the lower esophageal sphincter 44. The tissue is
comprised of three layers; a mucosa 48 inner layer, a submucosa 50
middle layer and a muscle 52 outer layer. In a preferred
embodiment, collagen tissue in the submucosa 50 is targeted for
shrinkage. In addition, a coaling means to prevent damage to the
mucosa 48 may be incorporated into the LES tightening device 10.
This can be accomplished by cooling or cycling through cooled air,
liquid, or gel to inflate the balloon 20. The cooled material
dissipates the heat generated by absorption of the radiated energy
from the energy transmitting device 16. This maintains a safe
temperature level in the mucosa 46 (which is less than about
50.degree. C. or preferably less than 45.degree. C.) The type and
amount of cooled material used to inflate the balloon 20 is
dependent on the amount and type of energy generated within the
energy source 14.
[0026] FIG. 3 shows a second embodiment of the LES tightening
device 10. Reference numerals identical to those employed in
connection with FIG. 1 indicate identical elements, and reference
numerals followed by a suffix indicate modified but similar
elements. In this preferred embodiment, the energy transmitting
device 16A is attached to the outer surface of the balloon 20A to
direct energy at the lower esophageal sphincter 44 tissue. As
previously described, once the distal end 24 of the insertion
device 12 properly positions the energy transmitting device 16A
over the lower esophageal sphincter 44 tissue, the balloon 20A can
be inflated and the energy source 14 can transmit energy to the
energy transmitting device 16A for radiation onto the lower
esophageal sphincter 44 tissue. Again, a coolant can be used to
inflate the balloon 20A to prevent damage to the mucosa 48 while
achieving collagen shrinkage in the submucosa 50 resulting in the
tightening of the lower esophageal sphincter 44.
[0027] A third alternative embodiment to the present invention is
depicted in FIG. 4. Again, reference numerals identical to those
employed in connection with FIG. 1 indicate identical elements, and
reference numerals followed by a suffix indicate modified but
similar elements. In this embodiment, the balloon 20B is enlarged
to protrude into a stomach 46 and anchor or retain the energy
transmitting device 16B in proper position with respect to the
lower esophageal sphincter 44 tissue. In this embodiment, the
insertion device 12 positions the energy transmitting device 16B
such that the target area comprises the lower esophageal sphincter
44 tissue. Once in place, the balloon 20B is enlarged by injection
of a suitable material which retains the position of the energy
transmitting device 16B relative to the lower esophageal sphincter
44. This assures the energy radiated by the energy transmitting
device 16B is absorbed by the lower esophageal sphincter 44. Again,
the material injected into the balloon 20B for inflation can be
cooled to a sufficient level to offset and dissipate any heat
build-up in the mucosa 48 and thereby enable the generation of heat
and consequent shrinkage of collagen in the submucosa 50.
[0028] Although the present invention has been described with
reference to treatment of GERD by toning the muscular LES
sphincter, workers skilled in the art will recognize that this
device and method could be used to shrink or tone other sphincters
located in the body to overcome other medical ailments caused by
the loss of sphincter muscle tone. For example, the device and
method can be used on the urinary or anal sphincter to overcome
incontinence.
[0029] Furthermore, workers skilled in the art will also recognize
that changes may be made in form and detail without departing from
the spirit and scope of the invention. For example, the energy
source can generate energy of various wavelengths within the
electromagnetic spectrum including but not limited to laser, RF, or
microwave energy. Alternatively, the energy source can generate
ultrasonic energy to generate beat in the targeted tissue area. The
insertion device can be an endoscope, catheter or similar type of
device. Depending on the form and wavelength of the energy being
used, the energy transmitting device may be an antenna, an
ultrasonic transducer, a fiber optic bundle, or an electrical
resistance heater. Furthermore, a directional antenna can be used
to limit and control the amount of energy directed at specific
locations within the targeted tissue.
[0030] With the present invention, tissue within the lower
esophageal sphincter can be toned or tightened to treat
gastroesophageal reflux disease on an outpatient basis with a safe,
simple procedure with decreased aftercare, treatment and pain.
* * * * *